Reactive oxygen species (ROS), the fundamental cause of more than 90% of chronic disease, is unstable reactive oxygen species, which accumulation of excessive amount cause series of damages to human cells and ultimately organs. Humans are born with Superoxide Dismutase (SOD), an antioxidant enzyme that can defend against ROS, but amount and activity continually decrease as we age.
Genofocus is developing high-purity SOD, antioxidant enzyme, produced using microbial engineering & secreting expression technologies to develop SOD into therapeutic molecule. 4 Korea domestic patents and 1 US patent has been successfully registered. SOD producing strain is the first strain patent obtained in Korea, which has been developed as new drug to exert continuous antioxidant effect, removing ROS, to restore human homeostasis.